Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02SAD
|
|||
Former ID |
DNC007082
|
|||
Drug Name |
3-(2-(4-methoxycinnamyl)phenyl)acrylic acid
|
|||
Synonyms |
CHEMBL219590; 3-(2-(4-methoxycinnamyl)phenyl)acrylic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H18O3
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)C=CCC2=CC=CC=C2C=CC(=O)O
|
|||
InChI |
1S/C19H18O3/c1-22-18-12-9-15(10-13-18)5-4-8-16-6-2-3-7-17(16)11-14-19(20)21/h2-7,9-14H,8H2,1H3,(H,20,21)/b5-4+,14-11+
|
|||
InChIKey |
UIMOCAMZLBHNCQ-CTLAPNPFSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin E2 receptor EP2 (PTGER2) | Target Info | Inhibitor | [1] |
Prostaglandin E2 receptor EP3 (PTGER3) | Target Info | Inhibitor | [1] | |
Prostaglandin E2 receptor EP4 (PTGER4) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Inflammatory mediator regulation of TRP channels | ||||
Renin secretion | ||||
Pathways in cancer | ||||
cAMP signaling pathway | ||||
Calcium signaling pathway | ||||
Regulation of lipolysis in adipocytes | ||||
NetPath Pathway | FSH Signaling Pathway | |||
IL2 Signaling Pathway | ||||
IL4 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
Reactome | Prostanoid ligand receptors | |||
G alpha (s) signalling events | ||||
G alpha (i) signalling events | ||||
WikiPathways | Prostaglandin Synthesis and Regulation | |||
GPCRs, Class A Rhodopsin-like | ||||
Vitamin D Receptor Pathway | ||||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Ovarian Infertility Genes |
References | Top | |||
---|---|---|---|---|
REF 1 | Comparison between two classes of selective EP(3) antagonists and their biological activities. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5639-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.